Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study on Efficacy and Safety of Topiramate OROS® Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin
This study has been completed.
Study NCT00231647   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: September 30, 2005   Last Updated: May 11, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type 2
Diabetes Mellitus, Adult-Onset
Obesity
Additional conditions recognized in this trial
Diabetes Mellitus
More general conditions related to this trial
Body Weight
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Nutrition Disorders
Overnutrition
Overweight
Signs and Symptoms
Interventions listed in this trial
topiramate
Additional drug interventions recognized in this trial
Metformin
More general drug interventions related to this trial
Anti-Obesity Agents
Anticonvulsants
Central Nervous System Agents
Hypoglycemic Agents
Neuroprotective Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Johnson &Johnson Pharmaceutical Research &Development, L.L.C.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services